Invest in ‘triple rapid’ tests to fight mpox, H5N1 bird flu, and beyond
No FDA-approved rapid tests exist that specifically test for H5N1, and the first near-point-of-care test for mpox was approved by the WHO only in late October. Without widespread testing, we don’t know the true number of infections, don’t catch dangerous mutations early on, and can’t identify hotspots fast enough to contain the outbreak.
The New Republic on MSN1dOpinion
What to Expect From Trump’s Next Term: More E. Coli and Fewer VaccinesVirus monitoring, the budgets to investigate E. coli outbreaks, and much, much more could be on the chopping block.
Top government jobs offer less pay than the private sector, but remain highly coveted due to the power and influence. Here ...
A new study by the Centers for Disease Control and Prevention found that some dairy farm employees showed signs of ...
The study published Tuesday in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report ...
Had Avery Davis Bell had a miscarriage in Boston, where she lived until 2020, doctors could snap into action. But because she ...
Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...
Slapped cheek disease also called fifth disease is a contagious viral infection common in children Read to know all about the ...
Deaths from cardiovascular disease have surged among adults ages 25 to 64 living in rural areas, a new study shows.
Maggiy Emery is the executive director of Protect Minnesota, the state-based, statewide gun violence prevention organization ...
An MSU student has been diagnosed with bacterial meningitis, prompting swift action from the university and local health ...
"The concern is not just about what the Trump 2.0 Administration will do, but also about what it will say," writes Simon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback